Home > Income Statement > BALAXI PHARMACEUTICALS

BALAXI PHARMACEUTICALS
Revenue

    Back to Income Statement
BALAXI PHARMACEUTICALS is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for BALAXI PHARMACEUTICALS
Please provide your vote to see the results

BALAXI PHARMACEUTICALS Last 5 Year Revenue History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Net Sales ₹270 Cr₹293 Cr₹241 Cr₹336 Cr₹279 Cr

What is the latest Revenue of BALAXI PHARMACEUTICALS ?

The latest Revenue ratio of BALAXI PHARMACEUTICALS is ₹270 Cr based on Mar2026 Consolidated results.
Year Revenue
Mar2026₹270 Cr
Mar2025₹293 Cr
Mar2024₹241 Cr
Mar2023₹336 Cr
Mar2022₹279 Cr

How is Revenue of BALAXI PHARMACEUTICALS Trending?

Years Revenue % Change
Mar2026 ₹270 Cr
-7.65
Mar2025 ₹293 Cr
21.25
Mar2024 ₹241 Cr
-28.28
Mar2023 ₹336 Cr
20.42
Mar2022 ₹279 Cr -

Compare Revenue of peers of BALAXI PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BALAXI PHARMACEUTICALS ₹146.1 Cr 16.8% 19.8% -41.8% Stock Analytics
ADANI ENTERPRISES ₹371,326.0 Cr 0.3% 2.1% 10.5% Stock Analytics
ADITYA INFOTECH ₹48,883.6 Cr -5.4% -2% 164.9% Stock Analytics
AEGIS LOGISTICS ₹42,606.1 Cr -1.1% -11.2% 53.5% Stock Analytics
PREMIER ENERGIES ₹37,859.6 Cr -5.6% -7.9% -22.5% Stock Analytics
REDINGTON ₹26,807.1 Cr -0.4% -10.6% 15.5% Stock Analytics


BALAXI PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
BALAXI PHARMACEUTICALS

16.8%

19.8%

-41.8%

SENSEX

1.8%

11.1%

-1.6%


You may also like the below Video Courses